Skip to content
Subscriber Only

CureVac Coronavirus Vaccine Cleared for Human Trials in Germany

  • State-backed CureVac wins approval to test its product
  • Vaccine teaches body’s cells to identify and attack the virus

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Germany’s CureVac AG won approval to start human trials of a novel coronavirus vaccine just days after the company secured backing from Chancellor Angela Merkel’s government.